Pages that link to "Q42925508"

The following pages link to Shreya Goel (Q42925508):

Displaying 49 items.

• In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles (Q27342269) (← links)
• Nanobody: the "magic bullet" for molecular imaging? (Q30442626) (← links)
• Dynamic Positron Emission Tomography Imaging of Renal Clearable Gold Nanoparticles. (Q30759992) (← links)
• Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy (Q33687218) (← links)
• Intrinsically radiolabeled nanoparticles: an emerging paradigm (Q34315359) (← links)
• In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles (Q34446399) (← links)
• VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo. (Q34650180) (← links)
• VEGF₁₂₁-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system. (Q34674541) (← links)
• Matching the decay half-life with the biological half-life: ImmunoPET imaging with (44)Sc-labeled cetuximab Fab fragment (Q34764397) (← links)
• Iron oxide decorated MoS2 nanosheets with double PEGylation for chelator-free radiolabeling and multimodal imaging guided photothermal therapy (Q35153888) (← links)
• In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine. (Q35554806) (← links)
• Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery (Q35602386) (← links)
• PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment. (Q35674858) (← links)
• In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene (Q35856996) (← links)
• Dual-Modality Positron Emission Tomography/Optical Image-Guided Photodynamic Cancer Therapy with Chlorin e6-Containing Nanomicelles (Q36088634) (← links)
• Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging (Q36301189) (← links)
• Long circulating reduced graphene oxide-iron oxide nanoparticles for efficient tumor targeting and multimodality imaging. (Q37033916) (← links)
• Engineering Intrinsically Zirconium-89 Radiolabeled Self-Destructing Mesoporous Silica Nanostructures for In Vivo Biodistribution and Tumor Targeting Studies. (Q37404653) (← links)
• Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics (Q37649861) (← links)
• Molecular imaging with nucleic acid aptamers (Q37916658) (← links)
• Intrinsic radiolabeling of Titanium-45 using mesoporous silica nanoparticles (Q38729757) (← links)
• Cerenkov Radiation Induced Photodynamic Therapy Using Chlorin e6-Loaded Hollow Mesoporous Silica Nanoparticles. (Q38818714) (← links)
• Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics (Q38926681) (← links)
• Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview (Q39104249) (← links)
• Harnessing the Power of Nanotechnology for Enhanced Radiation Therapy (Q39378076) (← links)
• Surfactant-Stripped Frozen Pheophytin Micelles for Multimodal Gut Imaging (Q41628747) (← links)
• Facile Preparation of Multifunctional WS2 /WOx Nanodots for Chelator-Free 89 Zr-Labeling and In Vivo PET Imaging (Q42684488) (← links)
• Cancer theranostics with ⁶⁴Cu/¹⁷⁷Lu-loaded liposomes (Q42925462) (← links)
• ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment. (Q46198687) (← links)
• Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy (Q47228803) (← links)
• Intrabilayer 64Cu Labeling of Photoactivatable, Doxorubicin-Loaded Stealth Liposomes. (Q47294309) (← links)
• Chelator-Free Labeling of Metal Oxide Nanostructures with Zirconium-89 for Positron Emission Tomography Imaging. (Q47311021) (← links)
• Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging (Q47447811) (← links)
• Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody (Q47777542) (← links)
• A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imaging (Q48088727) (← links)
• Intrinsic and Stable Conjugation of Thiolated Mesoporous Silica Nanoparticles with Radioarsenic. (Q48272615) (← links)
• Renal-Clearable PEGylated Porphyrin Nanoparticles for Image-guided Photodynamic Cancer Therapy (Q49898945) (← links)
• Reassembly of 89 Zr-Labeled Cancer Cell Membranes into Multicompartment Membrane-Derived Liposomes for PET-Trackable Tumor-Targeted Theranostics. (Q50071465) (← links)
• Bacteria-like mesoporous silica-coated gold nanorods for positron emission tomography and photoacoustic imaging-guided chemo-photothermal combined therapy. (Q52675634) (← links)
• Chelator-Free Radiolabeling of Nanographene: Breaking the Stereotype of Chelation. (Q54530868) (← links)
• General synthesis of silica-based yolk/shell hybrid nanomaterials and tumor vasculature targeting (Q58560988) (← links)
• In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem (Q58582293) (← links)
• Auger electron-based targeted radioimmunotherapy with 58mCo, a feasibility study (Q59604645) (← links)
• Mathematical modeling in cancer nanomedicine: a review (Q64075041) (← links)
• Radiolabeled polyoxometalate clusters: Kidney dysfunction evaluation and tumor diagnosis by positron emission tomography imaging (Q88457167) (← links)
• Molecular targeting of FATP4 transporter for oral delivery of therapeutic peptide (Q91745581) (← links)
• Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer (Q91851340) (← links)
• A highly hemocompatible erythrocyte membrane-coated ultrasmall selenium nanosystem for simultaneous cancer radiosensitization and precise antiangiogenesis (Q93202529) (← links)
• Sequential deconstruction of composite drug transport in metastatic breast cancer (Q97424921) (← links)